UNSPSC 85813828: Introduction of electrolytic and water balance substance into joints, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of electrolytic and water balance substance into joints, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0U37Z

UNSPSC 85813828, Introduction of electrolytic and water balance substance into joints, percutaneous approach, is a Commodity code with negligible recent state and local procurement activity. The code nominally describes a clinical procedure—percutaneous injection of electrolytic or water balance agents into joints—but the recent opportunities posted under it do not align with this scope; instead, they reflect broad healthcare services solicitations across medical, behavioral health, and administrative domains that do not target joint-injection procedures specifically.

The most recent opportunities tagged to this code span virtual urgent care services from the Inland Empire Health Plan (IEHP, California, RFI due October 31, 2026), general medical services from DeKalb County Georgia (RFP due November 12, 2026), Program of All Inclusive Care for the Elderly (PACE) operations from Nevada Health Authority (RFP due December 10, 2026), and a broad range of ancillary clinical services including cancer registry, retinal screening, EMT staffing, employee health clinics, occupational health, and behavioral health programs from multiple counties and municipalities across California, Colorado, Florida, Georgia, Kansas, New Jersey, New York, Oregon, Texas, and Washington. The geographic spread encompasses no clear concentration; opportunities originate from state health departments, county behavioral health divisions, municipal fire departments, independent school districts, and health-system purchasing authorities. The mismatch between the code's clinical definition and the actual recent procurement suggests either persistent miscoding in state and local procurement systems or abandonment of this commodity code in actual practice. Pursue this code only if your firm specializes in joint-injection therapeutics and can demonstrate direct relevance to the nominal procedure; the recent opportunity stream does not support business development focus.